Director, Portfolio Growth Marketing
Galderma
Summary
The Director, Portfolio Growth Marketing, will be a leader responsible for identifying and translating portfolio growth opportunities across Galderma's injectable aesthetics business. This role will develop and execute key strategies that maximize portfolio growth, strengthen competitive advantage, and unlock opportunities across brands, customer segments, and the evolving aesthetics landscape. This role will sit at the intersection of portfolio strategy, consumer and customer insights, brand marketing, commercial execution, partnering closely with Sales, Medical Affairs, Finance, Insights, and other cross functional teams. The ideal candidate is an experienced marketing who can move fluidly between big picture portfolio thinking and practical commercial execution, identify where the business can win, and turn complex market dynamics into clear choices and action.
Job description
Key Responsibilities
- Lead US Injectable Aesthetics portfolio assessment to define market opportunities, threats and whitespace; deliver portfolio growth priorities and an actionable roadmap.
- Own the market and category plan, integrating KTL insights, congress and publications, field input and industry trends; delivering ad hoc and routine executive intelligence and strategic reports.
- Develop and execute growth strategies across the portfolio, including field force communications, sales training, response plans, competitive playbooks, readiness plans and sales/marketing tools, including keeping updated libraries of competitive tools.
- Establish KPIs and report on key metrics throughout execution.
- Build business cases for differentiated portfolio growth programs as directed by the leadership team. Examples include new approaches for external facing teams, and unique strategies to build growth in Galderma's loyalty and service models.
- Lead cross functional strategic initiatives and operating forums, including competitive readiness, congress intelligence, and portfolio reviews and follow through on priorities.
- Ensure that portfolio brand strategies are executed with a high attention to detail and a focus on 360-plan implementation across company channels.
- Ensure content development and promotional materials follow internal review/approval processes and local regulations.
- Support operational and execution capabilities, as required.
Qualifications
- Bachelor's degree required.
- Prior experience in sales and marketing is preferred.
- 8-12 years of relevant industry experience in large, complex organization.
- Aesthetics industry experience required.
- Relevant Pharmaceutical/medical device industry experience highly preferred.
- Proven ability to think strategically as well as execute and implement.
- Proven ability to collaborate with upstream partners and drive tactical, downstream marketing activities.
- Must be highly organized and able to perform multiple tasks at same time.
- Travel estimated up to 30%
Requirements
- Bachelor's degree required.
- Prior experience in sales and marketing is preferred.
- 8-12 years of relevant industry experience in large, complex organization.
- Aesthetics industry experience required.
- Relevant Pharmaceutical/medical device industry experience highly preferred.
- Proven ability to think strategically as well as execute and implement.
- Proven ability to collaborate with upstream partners and drive tactical, downstream marketing activities.
- Must be highly organized and able to perform multiple tasks at same time.
- Travel estimated up to 30%
Benefits
- Medical, Dental & Vision
- 401(k) Matching
- Paid Time Off
- Annual Incentive Program
Company overview
Galderma S.A. is a Swiss pharmaceutical company headquartered in Zug, Switzerland, specializing exclusively in dermatology. Founded in 1981 as a joint venture between L'Oréal and Nestlé, the company has evolved into the world's largest independent dermatology company. Galderma focuses on three core business segments: Injectable Aesthetics, Dermatological Skincare, and Therapeutic Dermatology. The company offers a comprehensive portfolio of premium brands including Cetaphil, Restylane, Azzalure, Dysport, and Sculptra, serving patients and consumers in over 100 countries. With approximately 6,500 employees globally, Galderma maintains a strong research and development presence across six sites worldwide. The company went public in 2024 with an IPO on the SIX Swiss Exchange, marking a significant milestone in its growth trajectory. Galderma's mission is to advance dermatology for every skin story, combining scientific innovation with trusted partnerships with healthcare professionals to deliver superior outcomes for diverse skin needs.